• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于胰岛素眼部递送的壳聚糖工程纳米颗粒的制剂开发与评价

Formulation development, and evaluation of chitosan engineered nanoparticles for ocular delivery of insulin.

作者信息

Rathore Priyanka, Mahor Alok, Jain Surendra, Haque Anzarul, Kesharwani Prashant

机构信息

Sagar Institute of Research and Technology Pharmacy Bhopal India.

Institute of Pharmacy, Bundelkhand University Jhansi India

出版信息

RSC Adv. 2020 Dec 8;10(71):43629-43639. doi: 10.1039/d0ra07640f. eCollection 2020 Nov 27.

DOI:10.1039/d0ra07640f
PMID:35519724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9058365/
Abstract

Insulin-dependent diabetic patients have to count on the administration of painful and discomforting insulin injections. However, inadequate insulin absorption and the risk of insulin level escalation in the blood are some disadvantages associated with insulin therapy. Thus, the current study intends to formulate insulin-loaded chitosan nanoparticles for refining the systemic absorption of insulin the ocular route. Insulin-loaded chitosan nanoparticles were prepared by the ionotropic gelation method and characterized for various parameters. Optimized insulin loaded nanoparticles (C4T4I4) were positively charged with a particle size of 215 ± 2.5 nm and showed 65.89 ± 4.3% entrapment efficiency. The drug release exhibited sustained release of insulin, where 77.2 ± 2.1% of release was observed after 12 h and leads to an assumption of the non-Fickian diffusion release mechanism. The permeation study discloses good mucoadhesive and better permeation properties of insulin loaded nanoparticles compared to free Insulin. No significant difference was observed in the size of particles after six months of storage, signifying their adequate stability. Nanoparticles were found to be non-irritant to ocular tissues and exhibited prominent blood glucose level reduction . The outcomes of this study suggested that the chitosan nanoparticulate system could act as a prominent carrier system for insulin with enhanced stability and efficacy.

摘要

胰岛素依赖型糖尿病患者不得不依靠注射带来疼痛和不适的胰岛素。然而,胰岛素吸收不足以及血液中胰岛素水平升高的风险是胰岛素治疗的一些缺点。因此,本研究旨在制备载胰岛素的壳聚糖纳米颗粒,以改善胰岛素通过眼部途径的全身吸收。通过离子凝胶法制备了载胰岛素的壳聚糖纳米颗粒,并对其各项参数进行了表征。优化后的载胰岛素纳米颗粒(C4T4I4)带正电荷,粒径为215±2.5nm,包封率为65.89±4.3%。药物释放显示胰岛素呈持续释放,12小时后释放率为77.2±2.1%,表明其符合非菲克扩散释放机制。渗透研究表明,与游离胰岛素相比,载胰岛素纳米颗粒具有良好的黏膜黏附性和更好的渗透性能。储存六个月后,颗粒大小没有显著差异,表明其稳定性良好。纳米颗粒对眼部组织无刺激性,并能显著降低血糖水平。本研究结果表明,壳聚糖纳米颗粒系统可作为一种出色的胰岛素载体系统,具有更高的稳定性和疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/5bf9cd93e188/d0ra07640f-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/534d0fbdc4be/d0ra07640f-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/89d0546a8e25/d0ra07640f-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/d5d6c988ae9c/d0ra07640f-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/01c3a1760771/d0ra07640f-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/5bf9cd93e188/d0ra07640f-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/534d0fbdc4be/d0ra07640f-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/89d0546a8e25/d0ra07640f-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/d5d6c988ae9c/d0ra07640f-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/01c3a1760771/d0ra07640f-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd9/9058365/5bf9cd93e188/d0ra07640f-f5.jpg

相似文献

1
Formulation development, and evaluation of chitosan engineered nanoparticles for ocular delivery of insulin.用于胰岛素眼部递送的壳聚糖工程纳米颗粒的制剂开发与评价
RSC Adv. 2020 Dec 8;10(71):43629-43639. doi: 10.1039/d0ra07640f. eCollection 2020 Nov 27.
2
Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.新型肽接枝 Cs 的合成与表征及其纳米粒用于胰岛素口服给药的研究:体外与体内评价。
Int J Nanomedicine. 2018 Sep 6;13:5127-5138. doi: 10.2147/IJN.S161240. eCollection 2018.
3
Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment.基于粘蛋白-壳聚糖复合物的胰岛素载药黏膜黏附纳米粒用于口服给药和糖尿病治疗。
Carbohydr Polym. 2020 Feb 1;229:115506. doi: 10.1016/j.carbpol.2019.115506. Epub 2019 Nov 4.
4
Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.盐酸倍他洛尔载壳聚糖纳米粒的眼部给药及其抗青光眼作用。
Curr Drug Deliv. 2013 Oct;10(5):493-9. doi: 10.2174/1567201811310050001.
5
Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.由壳聚糖的季铵化N-芳基衍生物制备的冻干胰岛素纳米颗粒作为胰岛素口服递送的新策略:体外、离体和体内表征
Drug Dev Ind Pharm. 2014 Dec;40(12):1645-59. doi: 10.3109/03639045.2013.841187. Epub 2013 Oct 4.
6
Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.载酮咯酸氨丁三醇壳聚糖纳米粒的制剂与角膜渗透性
Drug Dev Ind Pharm. 2016;42(4):514-24. doi: 10.3109/03639045.2015.1081236. Epub 2015 Sep 25.
7
Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development, & Characterization.研究壳聚糖纳米粒凝胶的保留潜力:设计、开发和特性研究。
Recent Pat Antiinfect Drug Discov. 2020;15(1):41-67. doi: 10.2174/1574891X14666191014141558.
8
Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.壳聚糖-海藻酸钠纳米粒作为眼部给药的亚微观载体:制剂、优化及体外表征
Eur J Pharm Biopharm. 2008 Mar;68(3):513-25. doi: 10.1016/j.ejpb.2007.09.009. Epub 2007 Sep 25.
9
Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.克拉霉素负载眼用壳聚糖纳米粒:制剂、优化、表征、眼部刺激性和抗菌活性。
Int J Nanomedicine. 2020 Oct 13;15:7861-7875. doi: 10.2147/IJN.S269004. eCollection 2020.
10
Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.载有司来吉兰的壳聚糖纳米颗粒在帕金森病治疗中的生物制药潜力
Curr Drug Discov Technol. 2019;16(4):417-425. doi: 10.2174/1570163815666180418144019.

引用本文的文献

1
QbD-Based Development of Fluocinolone Nanocomposite Transdermal Gel: Optimization, Characterization, and Enhanced Anti-hyperpigmentation Efficacy Assessment.基于质量源于设计的氟轻松纳米复合透皮凝胶的开发:优化、表征及增强的抗色素沉着功效评估
AAPS PharmSciTech. 2025 Apr 2;26(4):100. doi: 10.1208/s12249-025-03094-8.
2
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.叶酸修饰壳聚糖纳米粒:新一代抗癌纳米载体。
Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z.
3
Development of chitosan lipid nanoparticles to alleviate the pharmacological activity of piperine in the management of cognitive deficit in diabetic rats.

本文引用的文献

1
Nanoparticles: Oral Delivery for Protein and Peptide Drugs.纳米粒:蛋白和多肽类药物的口服递药系统
AAPS PharmSciTech. 2019 May 20;20(5):190. doi: 10.1208/s12249-019-1325-z.
2
Recent Updates on Novel Approaches in Insulin Drug Delivery: A Review of Challenges and Pharmaceutical Implications.胰岛素药物传递新方法的最新进展:挑战与药物制剂学意义的综述。
Curr Drug Targets. 2018;19(15):1782-1800. doi: 10.2174/1389450119666180523092100.
3
Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review.
壳聚糖脂质纳米粒的研制缓解胡椒碱在糖尿病大鼠认知功能障碍管理中的药理活性。
Sci Rep. 2024 Apr 8;14(1):8247. doi: 10.1038/s41598-024-58601-x.
4
Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery.用于鼻内给药的卡巴拉汀与胰岛素组合的黏膜黏附纳米颗粒的合成
Polymers (Basel). 2024 Feb 13;16(4):510. doi: 10.3390/polym16040510.
5
Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media.用于鼻内给药的载胰岛素黏膜黏附纳米颗粒的合成:聚焦于新型扩散介质
Front Pharmacol. 2023 Aug 28;14:1227423. doi: 10.3389/fphar.2023.1227423. eCollection 2023.
6
Chitosan-Based Particulate Carriers: Structure, Production and Corresponding Controlled Release.基于壳聚糖的微粒载体:结构、制备及相应的控释
Pharmaceutics. 2023 May 10;15(5):1455. doi: 10.3390/pharmaceutics15051455.
7
Chitosan-Based Nanoparticles as Effective Drug Delivery Systems-A review.壳聚糖纳米粒子作为有效的药物传递系统-综述。
Molecules. 2023 Feb 18;28(4):1963. doi: 10.3390/molecules28041963.
8
Preparation and Evaluation of Modified Chitosan Nanoparticles Using Anionic Sodium Alginate Polymer for Treatment of Ocular Disease.使用阴离子海藻酸钠聚合物制备及评估用于眼部疾病治疗的改性壳聚糖纳米颗粒
Pharmaceutics. 2022 Dec 14;14(12):2802. doi: 10.3390/pharmaceutics14122802.
9
Thermo-Responsive Gel Containing Hydroxytyrosol-Chitosan Nanoparticles (Hyt@tgel) Counteracts the Increase of Osteoarthritis Biomarkers in Human Chondrocytes.含有羟基酪醇-壳聚糖纳米颗粒的热响应凝胶(Hyt@tgel)可对抗人软骨细胞中骨关节炎生物标志物的增加。
Antioxidants (Basel). 2022 Jun 20;11(6):1210. doi: 10.3390/antiox11061210.
10
Chitosan-Tripolyphosphate Nanoparticles Prepared by Ionic Gelation Improve the Antioxidant Activities of Astaxanthin in the In Vitro and In Vivo Model.通过离子凝胶法制备的壳聚糖-三聚磷酸钠纳米颗粒提高了虾青素在体外和体内模型中的抗氧化活性。
Antioxidants (Basel). 2022 Feb 28;11(3):479. doi: 10.3390/antiox11030479.
壳聚糖复合材料和壳聚糖纳米颗粒复合材料对各种药物递送系统的影响:综述
J Food Drug Anal. 2015 Dec;23(4):619-629. doi: 10.1016/j.jfda.2014.10.008. Epub 2014 Dec 4.
4
Recent perspectives on the delivery of biologics to back of the eye.眼部后部生物制剂递送的最新观点。
Expert Opin Drug Deliv. 2017 May;14(5):631-645. doi: 10.1080/17425247.2016.1227783. Epub 2016 Sep 6.
5
Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.用于眼部给药的载莫西沙星明胶纳米粒:制剂及体外、体内评价
J Colloid Interface Sci. 2016 Dec 1;483:132-138. doi: 10.1016/j.jcis.2016.08.018. Epub 2016 Aug 10.
6
Insulin delivery methods: Past, present and future.胰岛素给药方法:过去、现在与未来。
Int J Pharm Investig. 2016 Jan-Mar;6(1):1-9. doi: 10.4103/2230-973X.176456.
7
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes.基于纳米颗粒的胰岛素递送系统:1型糖尿病的下一代高效疗法。
J Nanobiotechnology. 2015 Oct 24;13:74. doi: 10.1186/s12951-015-0136-y.
8
Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.用于局部给药的眼部药物递送系统中的纳米颗粒:前景与挑战。
Curr Pharm Des. 2015;21(36):5212-24. doi: 10.2174/1381612821666150923095155.
9
Basics and recent advances in peptide and protein drug delivery.肽和蛋白质药物递送的基础与最新进展
Ther Deliv. 2013 Nov;4(11):1443-67. doi: 10.4155/tde.13.104.
10
Development of Chitosan Nanoparticles as a Stable Drug Delivery System for Protein/siRNA.壳聚糖纳米粒作为蛋白质/小干扰RNA稳定药物递送系统的研发
Int J Biomater. 2013;2013:146320. doi: 10.1155/2013/146320. Epub 2013 Sep 30.